Spliceosomic dysregulation unveils NOVA1 as a candidate actionable therapeutic target in pancreatic neuroendocrine tumors

SEBASTIAN EMILIO VENTURA SOTOJUAN MANUEL JIMÉNEZ VACASEMILIA Mª ALORS PÉREZRAUL MIGUEL LUQUE HUERTASMANUEL DAVID GAHETE ORTIZALEJANDRO IBÁÑEZ COSTAJUSTO PASTOR CASTAÑO FUENTESANTONIO CARLOS FUENTES FAYOS2026-01-292026-01-29202310.1016/j.trsl.2022.07.0052-s2.0-85136218715https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/35298Biochemistry (medical)Physiology (medical)Public Health, Environmental and Occupational HealthSpliceosomic dysregulation unveils NOVA1 as a candidate actionable therapeutic target in pancreatic neuroendocrine tumorsresearch article